Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-10-26-Speech-3-299-000"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2011-10-26"^^xsd:date2
dcterms:Is Part Of	lp_eu:Public health threat of antimicrobial resistance (debate)2
dcterms:Language	"sv"^^xsd:language2
lpv:document identification number	"en.20111026.20.3-299-000"2
lpv:hasSubsequent	lp_eu:2011-10-26-Speech-3-300-0002
lpv:speaker	lp:Åsa Westlund2
lpv:spokenAs	member; S&D (2009-07-14--2014-06-30)3 substitute; Delegation to the ACP-EU Joint Parliamentary Assembly (2009-09-16--2014-06-30)3 substitute; DEVE (2009-07-16--2012-01-18)3 member; Delegation for relations with the Palestinian Legislative Council (2011-02-16--2014-06-30)3 member; ENVI (2009-07-16--2012-01-18)3 unknown; Arbetarepartiet- Socialdemokraterna (2009-07-14--2014-06-30)3
lpv:translated text	"Mr President, not long ago I visited the doctor, and when he discovered that I was a Member of the European Parliament he asked me directly: what are you doing to combat antibiotics resistance? Far too little, I replied, but I also said that it is probably due to the fact that health care is an issue that does not primarily fall within the EU’s sphere of competence, but rather within that of the Member States. He then merely shook his head and said that if the EU does not do something about one of the biggest threats to our lives, with regard to which we are completely dependent on one another, then what is the purpose of the EU? I actually quite understand this reaction, and I am very pleased that we will have this resolution tomorrow and that the Commission will present a proposal. I am quite convinced that the Commission will have practical proposals for how we are to produce new antibiotics. I would therefore like to focus on something else and present a proposal that I hope you will be able to accept. One of the most important things to do, of course, is to produce comparable statistics that compare how antibiotics are used within the health-care sector in different Member States and in different regions, but also within animal husbandry in different countries, as well as how they are used for different animal species. Based on these statistics, we would need to establish reduction targets, because there really is no reason why one country should have very high use of antibiotics and other countries should have low use. We would also have a good opportunity to analyse and learn from good examples and to see what it is that is driving up antibiotics use in certain countries compared with others. Obviously it should be the case, as many speakers have said, that people should only be able to receive antibiotics after a doctor has issued a diagnosis and written a prescription. However, it is equally clear that it must not be possible for animals to receive antibiotics without having been examined by a veterinary surgeon who has determined what disease the animal has, and who then prescribes antibiotics for that disease. It must not be the case that antibiotics are given to animals more casually than to children who are sick."@en1
lpv:videoURI	<go to Events_and_structure europarl>2

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph